- Q4 2023 Amicus Therapeutics Inc Earnings Call TranscriptFeb 28, 2024$12.85 (-7.75%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Amicus Therapeutics Inc at UBS BioPharma Conference TranscriptNov 09, 2023
- Q3 2023 Amicus Therapeutics Inc Earnings Call TranscriptNov 08, 2023$11.37 (-2.10%)Earnings
- Amicus Therapeutics Inc to Discuss the FDA Approval Call TranscriptSep 28, 2023
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Amicus Therapeutics Inc Earnings Call TranscriptAug 08, 2023$11.09Earnings
- Amicus Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 11, 2023
- Q1 2023 Amicus Therapeutics Inc Earnings Call TranscriptMay 10, 2023$11.09Earnings
- Q4 2022 Amicus Therapeutics Inc Earnings Call TranscriptMar 01, 2023$11.09Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 Amicus Therapeutics Inc Earnings Call TranscriptNov 07, 2022$11.09Earnings
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 14, 2022
- Q2 2022 Amicus Therapeutics Inc Earnings Call TranscriptAug 04, 2022$10.57 (+2.67%)Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- Amicus Therapeutics Inc at Bank of America Healthcare Conference TranscriptMay 11, 2022
- Q1 2022 Amicus Therapeutics Inc Earnings Call TranscriptMay 09, 2022$6.19 (-12.20%)Earnings
- Q4 2021 Amicus Therapeutics Inc Earnings Call TranscriptFeb 24, 2022$8.1 (-3.63%)Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2022
- Q3 2021 Amicus Therapeutics Inc Earnings Call TranscriptNov 09, 2021$11.54 (-5.32%)Earnings
- Amicus Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) TranscriptSep 30, 2021
- Amicus Therapeutics Inc and ARYA Sciences Acquisition IV Corp to Announce Formation of a Next-Generation Genetic Medicine Company Call TranscriptSep 29, 2021
- Amicus Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 10, 2021
- Q2 2021 Amicus Therapeutics Inc Earnings Call TranscriptAug 05, 2021$9.93 (+2.17%)Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2021
- Amicus Therapeutics Inc at UBS Global Healthcare Virtual Conference TranscriptMay 24, 2021
- Amicus Therapeutics Inc at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 12, 2021
- Q1 2021 Amicus Therapeutics Inc Earnings Call TranscriptMay 10, 2021$9.41 (-0.95%)Earnings
- Q4 2020 Amicus Therapeutics Inc Earnings Call TranscriptMar 01, 2021$11.75 (-3.35%)Earnings
- Amicus Therapeutics Inc to Discuss the Topline PROPEL Results - Conference Call TranscriptFeb 11, 2021
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- Amicus Therapeutics Inc at Credit Suisse Healthcare Conference (Virtual) TranscriptNov 09, 2020
- Q3 2020 Amicus Therapeutics Inc Earnings Call TranscriptNov 05, 2020$18.24Earnings
- Amicus Therapeutics Inc at Bank of America Merrill Lynch Global Healthcare Conference (Virtual) TranscriptSep 18, 2020
- Amicus Therapeutics Inc at Citi BioPharma Conference (Virtual) TranscriptSep 10, 2020
- Q2 2020 Amicus Therapeutics Inc Earnings Call TranscriptAug 10, 2020$10.19Earnings
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 10, 2020
- Q1 2020 Amicus Therapeutics Inc Earnings Call TranscriptMay 07, 2020$10.19Earnings
- Q4 2019 Amicus Therapeutics Inc Earnings Call TranscriptMar 02, 2020$9.88Earnings
- Amicus Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 14, 2020
- Q3 2019 Amicus Therapeutics Inc Earnings Call TranscriptNov 11, 2019$7.81Earnings
- Amicus Therapeutics Inc Analyst Day TranscriptOct 10, 2019
- Q2 2019 Amicus Therapeutics Inc Earnings Call TranscriptAug 08, 2019$12.36Earnings
- Amicus Therapeutics Inc Presents Positive Interim Clinical Data for CLN6 Batten Disease Conference Call TranscriptAug 01, 2019
- Amicus Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 12, 2019
- Amicus Therapeutics Inc and the University of Pennsylvania Expansion of Gene Therapy Collaboration - Call TranscriptMay 29, 2019
- Amicus Therapeutics Inc at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Amicus Therapeutics Inc Earnings Call TranscriptMay 08, 2019$13.62Earnings
- Amicus Therapeutics Inc to Discuss the Preclinical Data Presented at ASGCT - Call TranscriptApr 30, 2019
- Amicus Therapeutics Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 Amicus Therapeutics Inc Earnings Call TranscriptFeb 28, 2019$12.37Earnings
- Amicus Therapeutics Inc to Discuss the Clinical Pompe Disease Data and Preclinical Batten Disease Data Presented at the WORLDSymposium TranscriptFeb 07, 2019
Amicus Therapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Hello, everyone. I'm Kristen Kluska, one of the biotechnology analyst at Cantor. It's my pleasure to host Amicus Therapeutics today, which is a company that I'm covering. And joining me on this fireside chat is John Crowley, the Chairman and CEO. Thank you so much for joining us and for being in our conference today.
Yes, Kristen, good morning. Thank you for having me.
Questions & Answers
Great. So, I'll start the focus of questions on AT-GAA for Pompe disease, especially considering you just announced the FDA acceptance of your filings yesterday. I think it would be helpful to first contextualize the current market centered around current standard of care, Lumizyme. While patients may start treatments at different times of their life at different levels of severity, could you please touch on the trends that have been observed with this
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)